Liberation Bioindustries, Inc. — Form D
Liberation Bioindustries, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-28. The offering totals $20.0M, of which $9.1M was reported sold. Industry: Manufacturing.
Offering
- Filed: 2022-10-28
- Form: D
- Accession: 0001952448-22-000001
- Industry: Manufacturing
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $9.1M
- Remaining: $10.9M
- Minimum investment: $25K
- Investors: 4
- Date of first sale: 2022-10-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-463127
Issuer
- Name: Liberation Bioindustries, Inc.
- CIK: 0001952448
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 14 Wall Street, NEW YORK, NY, 10005
- Phone: 917-539-8620
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Etan Bendheim | Director | New York, NY |
| Anthony Chow | Director | Douglas, Y8 |
| Philip Boigner | Director | New York, NY |
| James Mellon | Director | New York, NY |
| Etan Bendheim | Executive Officer | New York, NY |
| Mark Warner | Director | New York, NY |
| Mark Warner | Executive Officer | New York, NY |
| Babar Khan | Director | SAN DIEGO, CA |
| Steven Finn | Director | SAN DIEGO, CA |
Other filings by this issuer (2)
More